239 related articles for article (PubMed ID: 28870843)
21. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.
Winter PM; Pearce J; Chu Z; McPherson CM; Takigiku R; Lee JH; Qi X
J Magn Reson Imaging; 2015 Apr; 41(4):1079-87. PubMed ID: 24797437
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylserine targeting for diagnosis and treatment of human diseases.
Schutters K; Reutelingsperger C
Apoptosis; 2010 Sep; 15(9):1072-82. PubMed ID: 20440562
[TBL] [Abstract][Full Text] [Related]
23. Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Vallabhapurapu SL; Franco RS; Mierzwa M; Kassing W; Barrett WL; Qi X
Oncotarget; 2019 Jan; 10(8):856-868. PubMed ID: 30783515
[TBL] [Abstract][Full Text] [Related]
24. Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
Davis HW; Kaynak A; Vallabhapurapu SD; Qi X
World J Gastrointest Oncol; 2021 Jun; 13(6):550-559. PubMed ID: 34163572
[TBL] [Abstract][Full Text] [Related]
25. Prolonged storage of red blood cells affects aminophospholipid translocase activity.
Verhoeven AJ; Hilarius PM; Dekkers DW; Lagerberg JW; de Korte D
Vox Sang; 2006 Oct; 91(3):244-51. PubMed ID: 16958837
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells.
Audo R; Hua C; Hahne M; Combe B; Morel J; Daien CI
PLoS One; 2017; 12(1):e0169755. PubMed ID: 28072868
[TBL] [Abstract][Full Text] [Related]
27. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages.
Krahling S; Callahan MK; Williamson P; Schlegel RA
Cell Death Differ; 1999 Feb; 6(2):183-9. PubMed ID: 10200565
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E inhibits anti-Fas-induced phosphatidylserine oxidation but does not affect its externalization during apoptosis in Jurkat T cells and their phagocytosis by J774A.1 macrophages.
Serinkan BF; Tyurina YY; Babu H; Djukic M; Quinn PJ; Schroit A; Kagan VE
Antioxid Redox Signal; 2004 Apr; 6(2):227-36. PubMed ID: 15025924
[TBL] [Abstract][Full Text] [Related]
29. Annexin A5 as a targeting agent for cancer treatment.
Woodward A; Faria GNF; Harrison RG
Cancer Lett; 2022 Oct; 547():215857. PubMed ID: 35940392
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm.
Lee SH; Meng XW; Flatten KS; Loegering DA; Kaufmann SH
Cell Death Differ; 2013 Jan; 20(1):64-76. PubMed ID: 22858544
[TBL] [Abstract][Full Text] [Related]
31. Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy.
Wang W; Wu S; Cen Z; Zhang Y; Chen Y; Huang Y; Cillo AR; Prokopec JS; Quarato G; Vignali DAA; Stewart-Ornstein J; Li S; Lu B; Gong YN
Cell Rep; 2022 Nov; 41(5):111582. PubMed ID: 36323258
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylserine, a death knell.
Schlegel RA; Williamson P
Cell Death Differ; 2001 Jun; 8(6):551-63. PubMed ID: 11536005
[TBL] [Abstract][Full Text] [Related]
33. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
Xu FY; Queen G; Brandes L; Hatch GM
Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
[TBL] [Abstract][Full Text] [Related]
34. Transbilayer phospholipid movements in ABCA1-deficient cells.
Williamson P; Halleck MS; Malowitz J; Ng S; Fan X; Krahling S; Remaley AT; Schlegel RA
PLoS One; 2007 Aug; 2(8):e729. PubMed ID: 17710129
[TBL] [Abstract][Full Text] [Related]
35. Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes.
Janko C; Jeremic I; Biermann M; Chaurio R; Schorn C; Muñoz LE; Herrmann M
Phys Biol; 2013 Dec; 10(6):065006. PubMed ID: 24304966
[TBL] [Abstract][Full Text] [Related]
36. Targeting Phosphatidylserine with a
Perreault A; Richter S; Bergman C; Wuest M; Wuest F
Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
[TBL] [Abstract][Full Text] [Related]
37. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.
van Genderen HO; Kenis H; Hofstra L; Narula J; Reutelingsperger CP
Biochim Biophys Acta; 2008 Jun; 1783(6):953-63. PubMed ID: 18334229
[TBL] [Abstract][Full Text] [Related]
38. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes.
Fan X; Krahling S; Smith D; Williamson P; Schlegel RA
Mol Biol Cell; 2004 Jun; 15(6):2863-72. PubMed ID: 15064349
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
